Publication | Closed Access

Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy

Cell-based Drug DeliveryNanomedicineEngineeringBioreduction-ruptured NanogelPolymer-drug ConjugateTherapeutic NanomaterialsBreast CancerTumor TargetingBreast Tumor TherapyBiomedical EngineeringNano-drug DeliveryRadiation OncologyBcl2 Sirna